Related Experiment Video

Updated: Aug 7, 2026

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

Impact of the matrix metalloproteinase MMP-3 on dementia

Nicole Helbecque1, Dominique Cottel, Xavier Hermant

  • 1INSERM U744, Institut Pasteur de Lille, Lille Cedex, France.

Neurobiology of Aging
|July 11, 2006
PubMed

Insights

Matrix metalloproteinases (MMPs) may play a role in Alzheimer's disease (AD) risk. The MMP-3 6A/6A genotype, particularly in APOE epsilon4 non-carriers, is linked to an increased risk of dementia.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Alzheimer's disease (AD) pathogenesis involves cerebral beta-amyloid peptide (Abeta) accumulation.
  • Proteases are implicated in Abeta clearance, with matrix metalloproteinases (MMPs) being potential candidates.
  • A specific functional polymorphism (5A/6A) in the MMP-3 gene has been identified.

Purpose of the Study:

  • To investigate the association between the MMP-3 gene polymorphism and dementia risk.
  • To explore the interaction between MMP-3 genotype and APOE epsilon4 status in relation to dementia risk.

Main Methods:

  • Two independent studies were conducted.
  • Genotyping for the MMP-3 -1171 (5A/6A) polymorphism was performed.
  • Analysis included assessment of dementia risk in relation to MMP-3 genotype and APOE epsilon4 carrier status.

Main Results:

  • Subjects who were homozygous for the 6A/6A allele of the MMP-3 polymorphism showed an increased risk of dementia.
  • This increased risk was particularly evident in individuals who were non-carriers of the APOE epsilon4 allele.
  • Findings suggest a gene-environment interaction influencing dementia risk.

Conclusions:

  • The MMP-3 gene polymorphism may influence the risk of developing dementia.
  • MMPs are likely involved in the mechanisms underlying Abeta clearance and AD pathogenesis.
  • Further research into MMPs' role in neurodegenerative diseases is warranted.

More Related Videos

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.